 Geovax Labs Inc NASDAQ: GOVX is trading significantly higher Friday after the company announced it presented data from ongoing studies of its preventive vaccine against COVID-19 at the European Society of Medicine General Assembly. Using its novel Modified Virus Ankara-Virus Like Particle GV-MVA-VLP platform, GeoVax has developed a design strategy for vaccines expected to induce broader immunity through inclusion of multiple structural and nonstructural proteins from the target pathogen. 